CI
SLXP

Cowen Inc’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Cowen Inc’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-163,200
Closed -$26.2M – 570
2015
Q1 		$26.2M Buy
163,200
+142,576
+691% +$20.9M 2.17% 9
2014
Q4 		$2.37M Sell
20,624
-65,250
-76% -$7.9M 0.19% 91
2014
Q3 		$13.4M Buy
85,874
+73,374
+587% +$10.6M 1.38% 13
2014
Q2 		$1.54M Buy
+12,500
New +$1.38M 0.17% 120

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Cowen Inc's SLXP Position: Q2 2015 in Review

Cowen Inc sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 163,200 shares — an estimated $26.2M sold.

Cowen Inc first reported a position in SLXP in Q2 2014 and held it in 4 quarters. The position peaked at $26.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Cowen Inc reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Cowen Inc sold 163,200 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $26.2M.
  • Cowen Inc first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2014 and held it in 4 quarters.
  • Cowen Inc's SALIX PHARMACEUTICALS LTD DEL position peaked at $26.2M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Cowen Inc's 13F filing for Q2 2015, filed 14 Aug 2015.